ESR1 and breast neoplasm: Although many studies have identified heterogeneity in risk factor associations based on breast tumor subtypes defined by hormone receptor status (e.g. ER-positive vs. ER-negative) or histology (lobular vs. ductal)11–22, limited data have examined whether E-cadherin may define important subgroups of tumors with distinct etiologies23.